Divi’s Laboratories Reports Strong Q4 Performance, Net Profit Rises 13%
Divi’s Laboratories, a leading global manufacturer of active pharmaceutical ingredients (APIs), announced a robust financial performance for the fourth quarter ended March 31, 2024. The company reported a 13% year-on-year increase in net profit, reaching ₹751 crore, driven by strong sales and operational efficiencies. The company’s board also declared an interim dividend of ₹30 per…